Department of Otolaryngology

Medicine & Life Sciences

1. Taiwan 100%
2. Sudden Hearing Loss 91%
3. Sensorineural Hearing Loss 78%
4. Population 60%
5. Nasopharyngeal Carcinoma 48%
6. Salivary Gland Calculi 42%
7. Cohort Studies 42%
8. Cochlear Implants 41%
9. Nose 34%
10. Databases 31%
11. Myringoplasty 28%
12. Trachea 26%
13. Confidence Intervals 26%
14. Neck 26%
15. Hearing 24%
16. Case-Control Studies 24%
17. Child 23%
18. Obstructive Sleep Apnea 23%
19. Incidence 22%
20. Neoplasms 22%
21. Otolaryngology 22%
22. Hearing Loss 22%
23. Hydroxymethylglutaryl-CoA Reductase Inhibitors 22%
24. Ovalbumin 22%
25. Health Insurance 21%
26. Tympanoplasty 20%
27. Odds Ratio 20%
28. Head and Neck Neoplasms 20%
29. Survival 19%
30. Allergic Rhinitis 18%
31. Mouth Neoplasms 17%
32. Radiotherapy 17%
33. Squamous Cell Carcinoma of Head and Neck 17%
34. Ear Canal 16%
35. ovatodiolide 16%
36. Cholesteatoma 15%
37. Logistic Models 15%
38. Otitis Media 15%
39. poly(lactide) 15%
40. Nasopharyngeal Neoplasms 14%
41. Neoplasm Metastasis 14%
42. Therapeutics 14%
43. hesperetin 13%
44. Smartphone 13%
45. Temperature 13%
46. Sialadenitis 13%
47. Xylazine 13%
48. Smooth Muscle 13%
49. Solid-State Lasers 13%
50. Rolipram 13%
51. Carcinoma 13%
52. Tissue Engineering 13%
53. Comorbidity 12%
54. Salivary Glands 12%
55. Salivary Ducts 12%
56. Head 12%
57. Foreign Bodies 12%
58. Clear-cell metastatic renal cell carcinoma 12%
59. Histiocytic Necrotizing Lymphadenitis 12%
60. Sinusitis 11%
61. Tympanic Membrane Perforation 11%
62. Retrospective Studies 11%
63. Squamous Cell Carcinoma 11%
64. Type 4 Cyclic Nucleotide Phosphodiesterase 11%
65. Down-Regulation 11%
66. Zinc 11%
67. Parotid Gland 11%
68. Phosphodiesterase 4 Inhibitors 11%
69. Ketamine 11%
70. Tongue 11%
71. Transplants 11%
72. Mechanistic Target of Rapamycin Complex 1 11%
73. Electric Stimulation 10%
74. National Health Programs 10%
75. Systemic Lupus Erythematosus 10%
76. Bell Palsy 10%
77. Pediatrics 10%
78. Submandibular Gland 10%
79. Guinea Pigs 10%
80. Autophagy 10%
81. Vocal Cords 10%
82. Annexins 10%
83. Bone Conduction 10%
84. hesperetin-7,3'-O-dimethylether 10%
85. Laser Lithotripsy 9%
86. Audiometry 9%
87. Tension-Type Headache 9%
88. Retinal Vein Occlusion 9%
89. Facial Nerve 9%
90. Temozolomide 9%
91. Medicine 9%
92. Tonsillectomy 9%
93. Triple Negative Breast Neoplasms 9%
94. Phosphoric Diester Hydrolases 9%
95. Nasal Obstruction 9%
96. Iron-Deficiency Anemias 9%
97. Neonatal Screening 9%
98. Coronary Disease 8%
99. Stroke 8%